Steadfast Group (ASX: SDF) — Investment Research Report
3-Year / 5-Year Price Scenarios (with probabilities): Four-Master Analysis
Key metrics
| Price | $5.23 |
|---|---|
| Market cap | $5.8B |
| P/E (TTM) | 16.2 |
| Forward P/E | 15.6 |
| Dividend yield | 3.8% |
| Analyst target | $6 |
| 52-week range | $3.87 – $6.67 |
| 5y downside | -22.0% |
Four-master scores
| Business | 4 / 5 |
|---|---|
| Moat | 4 / 5 |
| Management | 3 / 5 |
| Risk | 3 / 5 |
| Civilization | 3 / 5 |
| Valuation | 3 / 5 |
| Total | 20 |
Verdict — special
SPECIAL SITUATION — live A$6.00 takeover by a KKR/Amwins/Dragoneer consortium. Merger-arb, not a fundamental hold; ~72% chance cashed out at ~A$6.00 within a year. Underlying business is genuinely excellent.
3-Year / 5-Year Price Scenarios
Base EPS: $0.28 — STANDALONE underlying EPS if the deal fails (AUD). The takeover outcome dominates near-term.
3-year price scenarios
| Case | Prob. | Target | Upside | Growth | P/E |
|---|---|---|---|---|---|
| Bull | 30.0% | $7.1 | 35.0% | 12.0% | 18 |
| Base | 45.0% | $5.3 | 1.0% | 8.0% | 15 |
| Bear | 25.0% | $3.7 | -30.0% | 3.0% | 12 |
| Weighted | $5.84 | 12.0% |
5-year price scenarios
| Case | Prob. | Target | Upside | Growth | P/E |
|---|---|---|---|---|---|
| Bull | 30.0% | $8.9 | 70.0% | 12.0% | 18 |
| Base | 42.0% | $6.2 | 18.0% | 8.0% | 15 |
| Bear | 28.0% | $3.9 | -26.0% | 3.0% | 12 |
| Weighted | $6.06 | 16.0% |
0. Information Richness & AI Limitations
Information richness: Grade A (abundant). ASX100 constituent, Australia's insurance-broking leader, dense analyst coverage, and now heavy media attention because it is being acquired.
Grade-A trap: consensus is strong and current pricing is dominated by the takeover offer. The key reverse-check: at A$5.23 vs the A$6.00 offer, what is the market worried about? (Answer: the bid is non-binding, needs ACCC antitrust approval, and due diligence is unfinished.)
Core question: SDF is no longer a normal '3/5-year fundamentals' question — it is a merger-arbitrage question: (1) will the deal complete at A$6.00? (2) if it fails, what is the standalone fundamental value?
Key facts / caveats:
- Ticker correction: 'ASX:SDP' does not exist (404); confirmed to mean SDF — Steadfast Group.
- Under takeover: KKR (joined 2026-07-14) + Amwins + Dragoneer, A$6.00/share, ~A$7.7B, 52% premium to the pre-bid price; non-binding; exclusivity signed 2026-06-10 (extended 4 weeks); due diligence ongoing. Structure: KKR+Dragoneer take the retail brokerage; Amwins takes the underwriting agencies.
- Statutory vs underlying: statutory profit includes acquisition step-up gains (TTM net income A$355.5M, PE 16.2); underlying EPS FY25 was 26.7c — the true operating metric; forward PE 15.6x on underlying.
- Price: A$5.23 now (pre-bid ~A$3.95; 52-week range A$3.87–6.67); market cap A$5.80B (verified within 0.09%).
1. Data & Cross-Validation
Current pricing (mid-July 2026): price A$5.23 (~13% below the A$6.00 offer — the arbitrage spread); 1.11B shares; market cap A$5.80B (5.23 × 1.11B = 5.81B, 0.09% deviation ✓). Forward PE 15.6x; underlying EPS FY25 26.7c; dividend A$0.20 (3.79%, fully franked); 52-week A$3.87–6.67.
FY2025 results (why KKR wants it): revenue A$1.826B (+8.9%); underlying EBITA A$591.4M (+11.9%); underlying NPATA A$346.2M (+14.5%); underlying NPAT A$295.5M (+17.2%); underlying EPS 26.7c (+14.2%). Broker-network GWP A$12.5B (+6% like-for-like); underwriting-agency GWP A$2.5B (+5.9%).
FY2026 guidance: underlying NPAT A$315–325M; NPATA A$365–375M; EBITA A$650–665M; implies 6–10% EPS growth; assumes 3–5% premium rate rises.
Interpretation: a genuine capital-light compounder — underlying EPS growing double-digits, driven by organic GWP growth + premium rate increases + equity step-ups in network brokers + accretive bolt-on acquisitions (roll-up) + international (London, H.W. Wood) + InsurTech. This is among the highest-quality businesses of the 13 stocks analyzed — which is exactly why private equity wants it.
2. Business Essence — Duan Yongping ('the right business')
One line: Steadfast is the 'Walmart + franchise-master' of Australasian insurance broking — it aggregates hundreds of small independent brokers into one national network, giving them scale, technology and buying power in exchange for recurring commissions (tied to premium flow / GWP) and equity stakes. A capital-light, high-ROE, recurring-revenue distribution platform that can keep rolling up a fragmented market.
Why it's good: capital-light + high ROE + recurring 'toll-booth' income; network effects + scale (largest ANZ network); roll-up compounding in a fragmented market; multiple growth engines (organic GWP + rate rises + M&A + international + InsurTech, FY25 underlying EPS +14.2%). The 52% takeover premium is itself a validation of the quality.
But it's now a special situation: the A$6.00 offer dominates pricing — buying SDF today is a bet on deal completion, not on the business long-term. Business headwinds also exist: a softening premium cycle (2026 non-life real premium growth may slow to ~0.6%), commission regulation risk (the ACCC chair has called for a ban on strata insurance commissions; ASIC is reviewing broker commissions; fee-for-service risk), acquisition dependence, and an ASIC investigation into employee share trades.
Duan's verdict: an excellent toll-booth business — but right now it's a merger-arb, not an investment. The real Duan-style opportunity would be if the deal FAILS and the stock drops back toward A$4.
3. Moat — Buffett
| Moat | Assessment | Strength |
|---|---|---|
| Brand / pricing | ANZ broking leader; scale gives leverage over insurers | ★★★★☆ |
| Switching costs | Core moat: network brokers embedded in Steadfast's tech/back-office/arrangements, and Steadfast holds equity in them | ★★★★☆ |
| Network effects | More brokers → more scale/tech → more attractive network (virtuous circle) | ★★★★☆ |
| Scale | Largest ANZ network + agencies; cost leverage | ★★★★☆ |
| Roll-up platform | Consolidation capability in a fragmented market (hard to replicate) | ★★★★☆ |
Trend: the network/scale moat has widened for 5 years (M&A, internationalization, tech). The main future threat is commission regulation — if the commission model is forced to change, the moat's economics suffer. This is partly why PE wants to take it private (to handle regulation/transition away from quarterly market pressure).
Buffett question: the moat likely persists 10 years out — broking demand is durable, network position is hard to dislodge. The real threat is regulatory reform of commissions.
4. Reverse Thinking & Risks — Munger
| Failure path | Prob | Impact |
|---|---|---|
| Deal fails (ACCC block / DD breaks / consortium walks / price disagreement) | ~28% | High (falls to ~A$4.10) |
| ACCC antitrust blocks (Amwins is an industry player) | Med | High (can kill the deal) |
| Commission reform (strata ban, fee-for-service) | Med | Med-high |
| Soft premium cycle → organic commission growth slows | Med-high | Med |
| ASIC employee share-trade investigation escalates | Low-med | Med |
| CEO Kelly succession (if deal fails, adds key-person risk) | Low-med | Med |
This is a merger-arbitrage game. Munger's framing: when a good business gets a premium bid, the question is no longer 'is it good' but 'does the deal close.' A ~13% spread vs a ~20%+ break-downside is a mediocre-to-fair payoff; you need an independent view on ACCC approval and consortium intent. The simplest move for a non-arbitrageur: take profits near the offer price, or wait for clarity.
Munger question: why not load up at A$5.23? Because the A$6.00 bid is non-binding and must clear ACCC — the ~13% spread is exactly the market's pricing of deal-failure risk.
5. Management — Duan Yongping + Buffett
Robert Kelly (co-founder) built Steadfast into Australasia's largest broker network and roll-up platform — an outstanding founder and integrator with a strong long-term value-creation record. In 2024 he added London (H.W. Wood) and kept up disciplined, EPS-accretive M&A (A$238M in 1H, all accretive).
2026 events: Kelly announced his retirement (successor search via Spencer Stuart; to transition to non-executive director), then the A$6.00 takeover arrived (if the deal completes, Kelly intends to stay). Separately, ASIC issued an investigation notice over employee share trades (before a damaging ABC report) — a governance amber light to monitor.
Assessment: excellent founder-operator; but a key-person/succession transition is underway, and the ASIC probe is a governance blemish. Overall integrity record is good (regular disclosure, shareholder-friendly, rising dividends).
Duan question: if Kelly retires, does the company stay competitive? The network/scale moat is institutional and persists, but the roll-up/integration culture partly depends on Kelly. If PE acquires it, KKR/Amwins inject new management and capital to keep integrating.
6. Industry & Civilizational Trend — Li Lu
Not a paradigm shift. Insurance broking/distribution is a mature, stable, recurring financial-services niche. Demand is durable (all businesses need insurance; SME/commercial broking is sticky), premiums grow modestly with the economy and risk (climate, cyber). Weakly counter-cyclical but strongly recurring.
Value-chain position: the distribution/intermediary layer — connecting insurers and insured businesses. Solid position (earning commissions/fees), but constrained by commission regulation.
Roll-up runway: the global insurance-broking market is highly fragmented and a favorite PE roll-up sector (e.g., AJG, Brown & Brown, HUB, AssuredPartners in the US). Steadfast is the ANZ version — the runway remains long.
Regulatory headwind: commission transparency / conflicts / fee-for-service is the long-term global regulatory direction — a structural headwind.
Li Lu question: 20 years out it's a durable fee-collecting network — still the ANZ leader (or its private successor). That PE wants to take it private and roll it up away from public-market pressure is itself evidence of the long-term asset value.
7. Valuation & Scenarios (with probabilities) — Special Situation
This is merger-arb, not ordinary valuation. Price A$5.23 vs offer A$6.00 = 13% discount (the arb spread), reflecting deal-completion uncertainty. Standalone fundamentals (forward EPS ~28c, forward PE 15.6x) put 3-year base standalone value at ~A$5.3 — i.e., A$6.00 ≈ the standalone 3-year base value plus a bit, a 'full but fair' private-equity price. PE buys a quality asset at a fair price; long-term holders give up the standalone 5-year bull upside (A$8.9).
Layer 1 — Deal outcome tree (resolves ~6–12 months; dominates 3-year return):
| Outcome | Result price | vs A$5.23 | Probability |
|---|---|---|---|
| Completes @ A$6.00 (cash, delisted) | A$6.00 | +14.7% | 60% |
| Bumped/competing @ ~A$6.35 (cash) | A$6.35 | +21.4% | 12% |
| Fails → ~A$4.10, then compounds | ~A$4.10 | −21.6% | 28% |
| Near-term weighted | ≈ A$5.51 | +5% | 100% |
Layer 2 — Standalone value (only relevant if the deal fails; base underlying EPS A$0.28):
3-year: Bull 12% growth / 18x → A$7.1 (+35%); Base 8% / 15x → A$5.3 (+1%); Bear 3% / 12x → A$3.7 (−30%). 5-year: Bull → A$8.9 (+70%); Base → A$6.2 (+18%); Bear → A$3.9 (−26%).
Combined weighted expectation: near-term A$5.51 (+5%); 3-year ~A$5.84 (+12%, including delisting cash); 5-year mix ~A$6.06 (+16%). Crucial: if the deal completes (72%), you are cashed out at ~A$6.00 within ~1 year — there is no 3/5-year SDF price. Only the ~28% deal-fail branch has a fundamental path.
Key judgment: a fair, unspectacular merger-arb — ~13% spread to A$6.00, ~20%+ break-downside, ~72% completion. The main risk is ACCC approval (Amwins is an industry buyer). For long-term fundamental investors, the awkward part is being cash-ejected at A$6.00; the real value opportunity is if the deal fails and it drops to ~A$4.
Duan question ('would you hold for 5 years if the market closed?'): effectively void for SDF — it will most likely be privatized and you'll be forced out at A$6.00. The genuine Duan-style opportunity is a deal failure back to ~A$4.
8. Decision Memo
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality (Duan) | Capital-light, high-ROE, recurring commissions, network effects, roll-up — among the best of the 13 | ★★★★☆ |
| Moat (Buffett) | Network + scale + switching costs + roll-up — wide | ★★★★☆ |
| Management (Duan+Buffett) | Kelly excellent, but retiring + ASIC blemish | ★★★☆☆ |
| Biggest risk (Munger) | Deal failure / ACCC block (near-term) + commission regulation + soft premium cycle | ★★★☆☆ |
| Civilizational trend (Li Lu) | Mature, stable distribution; long roll-up runway; regulatory headwind | ★★★☆☆ |
| Valuation (Buffett+Duan) | Anchored to the A$6.00 offer; ~13% spread, ~20%+ break-downside | ★★★☆☆ |
Decision table (merger-arb lens):
- Have no position: (a) arb: small position for the ~13% spread (+ small bump optionality), but you must understand ACCC/non-binding risk (break to ~A$4.10, −20%+). (b) long-term: not a good long-term entry now — you'll likely be cash-ejected at A$6.00; the real long-term buy is if the deal FAILS and it drops to A$3.9–4.3.
- Hold a position: hold for the A$6.00 (a 52% premium), or take profits near A$6.00 to avoid break risk.
- Sell signals: price near/at A$6.00 (arb captured); ACCC opposition/escalation; consortium withdraws or cuts price.
- Add signals: a higher competing bid; OR the deal fails and it drops to A$3.9–4.3 (good business at a good price).
One-line conclusion: Steadfast is one of the highest-quality businesses of the 13 (capital-light, high-ROE, recurring commissions, network effects, roll-up) — but it is under a live A$6.00 (52% premium) takeover, so it is now a merger-arbitrage, not a long-term fundamental hold. If the deal completes (72%), you get ~A$6.00 cash within ~1 year (no 3/5-year price); only if it fails (28%) does it fall to ~A$4.10 and compound on excellent fundamentals (standalone 5-year base ~A$6.2, bull ~A$8.9). Arbitrageurs can take a small position for the spread; long-term investors are awkwardly placed now — the real opportunity is a deal failure. Do not treat SDF as a normal 3/5-year compounder — it is a deal.
Four-Master Commentary
Buffett: "Exactly the business I like — capital-light, collecting insurance tolls, rolling small brokers into a compounding network. No wonder KKR wants it. But it's already been priced. This is no longer 'buy a good business' — it's arbitrage on whether the deal closes. The 52% premium is generous; A$6.00 is fair. If I owned it I'd hold to completion; if I didn't, I'd rather the deal fell through and it dropped to A$4."
Munger: "Reverse it — how does this arb lose money? ACCC blocks it, or the consortium balks. A 13% spread against a 20%+ downside is mediocre, and the cash may be tied up a while. And Amwins is an industry buyer — antitrust is a real hurdle. Don't mistake a so-so arb for a sure bargain."
Duan Yongping: "A broker network is a good business — I'd happily hold it long-term. But it's been bid for; buying at A$5.23 is betting on the deal, not the business. I don't do arbitrage. My opportunity is if the deal fails and it drops to ~A$4 — that's when you buy a good company at a good price. For now, into the 'too-hard' pile."
Li Lu: "Insurance distribution is a durable, stable business with a long roll-up runway — which is precisely why smart PE wants to take it private and integrate it away from quarterly pressure. That itself proves the long-term value. For public shareholders, A$6.00 is a fair goodbye price; in 20 years the network is probably still collecting commissions — just perhaps no longer listed."
Analysis output, not investment advice. Scenario probabilities and scores are subjective analyst judgment. SDF is a special situation (live takeover) — a merger-arbitrage, not a normal fundamental hold. The user's original input 'SDP' was invalid and confirmed to mean SDF.